Rinderon and disease progression Patient Reports February 11, 2012

Rinderon Side Effects Report #5235609-9
Rinderon side effect was reported by a Physician from JAPAN on Feb 07, 2007. Male patient, 73 years of age, was diagnosed with lung neoplasm malignant, prophylaxis, cancer pain, hypercalcaemia of malignancy, angina pectoris and was treated with Rinderon. After drug was administered, patient experienced the following side effects: disease progression, respiratory disorder. Rinderon dosage: 1 MG, UNK. During the same period patient was treated with PROTECADIN, ETOPAN, ZOMETA, NIKORANMART. Patient died on 11/29/2006.

Rinderon Side Effects Report #4718947-5
Rinderon side effect was reported by a Physician from JAPAN on July 08, 2005. Female patient, 63 years of age, weighting 99.21 lb, was diagnosed with brain oedema, anaplastic astrocytoma and was treated with Rinderon. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaplastic astrocytoma, ascites, aspartate aminotransferase increased, blood glucose increased, brain oedema, candidiasis, disease progression, disseminated intravascular coagulation. Rinderon dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, AMLODIPINE BESYLATE, GASTER, SELBEX CAPSULES, PURSENNID. Patient was hospitalized. Patient died on 05/04/2005.